1. The Nurse View: Practice Pearls in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC

3. Checkpoint Inhibitors Approved in NSCLC

4. Immunotherapy vs Chemotherapy

5. Overview of Immune Regulation

6. Basics of Immunotherapy

7. CheckMate Trial Design

9. KEYNOTE Trial Design

10. Outcomes With Pembrolizumab

11. KEYNOTE-024 Trial Design

13. OAK Trial Design

15. Most Common TRAEs With Immunotherapy

16. Management of AEs

17. Grading of AEs

18. Management of irAEs Based on Grade

19. Management of Diarrhea/Colitis

20. Management of Pneumonitis

21. Management of Steroid-Refractory irAEs

22. Restarting Immunotherapy

23. Management of Hypothyroidism

24. Importance of Patient Education

25. The Future of Immunotherapy

26. Key Takeaways

27. Abbreviations

28. Abbreviations (cont)